Sun Pharma posts Rs 1,064 crore Q2 net

New Delhi: Sun Pharmaceutical Industries on Thursday reported a consolidated net profit at Rs 1,064.09 crore in the second quarter ended September 30.

The company had posted a consolidated net loss of Rs 269.6 crore in the same period last fiscal, Sun Pharma said in a regulatory filing.

Total revenue from operations during the period under review stood at Rs 8,123.35 crore as against Rs 6,937.63 crore in the year-ago quarter, it added.

During the quarter India sales were at Rs 2,515 crore, growth of 35 per cent over the second quarter last year, while the US finished dosage sales were at $339 million flat over the same period last year, the company said.

The sales in emerging markets were at $201 million, up by 3 per cent and that of the rest of world were at $161 million, a growth of 49 per cent.

Sun Pharma said its active pharmaceutical ingredients (API) clocked external sales of Rs 468 crore, up 10 per cent over the same quarter last fiscal.